SynapCell will attend the 13th EILAT Conference on New Antiepileptic Drugs and Devices!
Corinne ROUCARD, CEO and co-Founder will present you how the MTLE model provides an efficient way to identify new treatment for drug-resistant forms of focal epilepsies.

Make the Right Decision. Stop Guessing.